CDT
Price
$1.07
Change
-$0.26 (-19.55%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
3.06M
Intraday BUY SELL Signals
KTTA
Price
$0.84
Change
-$0.00 (-0.00%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
19.41M
Intraday BUY SELL Signals
Interact to see
Advertisement

CDT vs KTTA

Header iconCDT vs KTTA Comparison
Open Charts CDT vs KTTABanner chart's image
CDT Equity
Price$1.07
Change-$0.26 (-19.55%)
Volume$2.26K
Capitalization3.06M
Pasithea Therapeutics
Price$0.84
Change-$0.00 (-0.00%)
Volume$500
Capitalization19.41M
CDT vs KTTA Comparison Chart in %
CDT
Daily Signal:
Gain/Loss:
KTTA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CDT vs. KTTA commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDT is a Hold and KTTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CDT: $1.33 vs. KTTA: $0.84)
Brand notoriety: CDT and KTTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDT: 2626% vs. KTTA: 10%
Market capitalization -- CDT: $3.06M vs. KTTA: $19.41M
CDT [@Biotechnology] is valued at $3.06M. KTTA’s [@Biotechnology] market capitalization is $19.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDT’s FA Score shows that 1 FA rating(s) are green whileKTTA’s FA Score has 1 green FA rating(s).

  • CDT’s FA Score: 1 green, 4 red.
  • KTTA’s FA Score: 1 green, 4 red.
According to our system of comparison, KTTA is a better buy in the long-term than CDT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDT’s TA Score shows that 5 TA indicator(s) are bullish while KTTA’s TA Score has 4 bullish TA indicator(s).

  • CDT’s TA Score: 5 bullish, 3 bearish.
  • KTTA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CDT is a better buy in the short-term than KTTA.

Price Growth

CDT (@Biotechnology) experienced а +20.58% price change this week, while KTTA (@Biotechnology) price change was -0.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KTTA($19.4M) has a higher market cap than CDT($3.06M). CDT YTD gains are higher at: 3.906 vs. KTTA (-34.884). KTTA has higher annual earnings (EBITDA): -13.19M vs. CDT (-18.61M). KTTA has more cash in the bank: 4.12M vs. CDT (3.84M). KTTA has less debt than CDT: KTTA (0) vs CDT (1.88M). CDT (0) and KTTA (0) have equivalent revenues.
CDTKTTACDT / KTTA
Capitalization3.06M19.4M16%
EBITDA-18.61M-13.19M141%
Gain YTD3.906-34.884-11%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.84M4.12M93%
Total Debt1.88M0-
TECHNICAL ANALYSIS
Technical Analysis
CDTKTTA
RSI
ODDS (%)
Bullish Trend 2 days ago
64%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
47%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
40%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 6 days ago
73%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CDT
Daily Signal:
Gain/Loss:
KTTA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPC187.5810.67
+6.03%
MARATHON PETROLEUM Corp
LIF61.073.22
+5.57%
Life360 Inc Common Stock
TBPH19.990.16
+0.81%
Theravance Biopharma
EGHA10.33-0.02
-0.19%
Egh Acquisition Corp
WETH1.55-0.14
-8.28%
Wetouch Technology

CDT and

Correlation & Price change

A.I.dvisor tells us that CDT and CMND have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CDT and CMND's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDT
1D Price
Change %
CDT100%
+19.82%
CMND - CDT
32%
Poorly correlated
-5.83%
KTTA - CDT
25%
Poorly correlated
-0.62%
NRSN - CDT
23%
Poorly correlated
-1.06%
DNA - CDT
23%
Poorly correlated
-4.04%
HOTH - CDT
23%
Poorly correlated
-4.32%
More

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and FATE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
-0.62%
FATE - KTTA
32%
Poorly correlated
-5.69%
GNFTY - KTTA
28%
Poorly correlated
+10.96%
QNCX - KTTA
27%
Poorly correlated
-19.22%
CDT - KTTA
27%
Poorly correlated
+19.82%
ACET - KTTA
25%
Poorly correlated
-3.51%
More